Popular Articles on Diabetesnet.com
This list of presentations is designed to be a resource for people with diabetes, health care professionals, diabetes educators, and students. These presentations can be downloaded but the original authors should be referenced if used elsewhere.
Well, what about us! The “us” I am talking about is the growing number of T1D’s who have lived full, rich lives with diabetes, over a lifetime of many years. Sure, the diabetes world has been moving forward at a fairly snappy pace. Innovative technologies, creative tools and tricks, more accessible education and widespread social media connections have brought enrichment to many PWD’s. The battle for Medicare coverage of CGM’s for seniors has been won, thanks to warriors like Dr. Nick Argento of Maryland and many others who led the fight to win.
GLP-1 agonists are a group of medications that mimic the actions of glucagon-like peptide or GLP-1. GLP-1 is one of several naturally occurring incretin compounds that affect the body after they are released from the gut during digestion. Because of its name, GLP-1 might seem to act like glucagon that increases glucose production by the liver and raises glucose levels. Instead, GLP-1 lowers both glucose and glucagon levels. Despite their different actions, GLP-1 and glucagon are both derived from the same parent compound called proglucagon, hence the similarity in names.
As I drove to my training appointment, ready to put the 670G into Auto Mode for the first time, I reflected on my past week in Manual Mode. The Suspend Before Low feature was a real winner with me, cutting off my basal delivery before I went low. I’d also noticed a big improvement in the accuracy of the sensor, giving me confidence to let the pump take over control in Auto Mode.